Skip to main content
Top
Published in: Journal of Translational Medicine 1/2010

Open Access 01-12-2010 | Research

Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity

Authors: Kelly L Brown, Reza Falsafi, Winnie Kum, Pamela Hamill, Jennifer L Gardy, Donald J Davidson, Stuart Turvey, Brett B Finlay, David P Speert, Robert EW Hancock

Published in: Journal of Translational Medicine | Issue 1/2010

Login to get access

Abstract

Background

Activation of Toll-like receptors (TLRs) is widely accepted as an essential event for defence against infection. Many TLRs utilize a common signalling pathway that relies on activation of the kinase IRAK4 and the transcription factor NFκB for the rapid expression of immunity genes.

Methods

21 K DNA microarray technology was used to evaluate LPS-induced (TLR4) gene responses in blood monocytes from a child with an IRAK4-deficiency. In vitro responsiveness to LPS was confirmed by real-time PCR and ELISA and compared to the clinical predisposition of the child and IRAK4-deficient mice to Gram negative infection.

Results

We demonstrated that the vast majority of LPS-responsive genes in IRAK4-deficient monocytes were greatly suppressed, an observation that is consistent with the described role for IRAK4 as an essential component of TLR4 signalling. The severely impaired response to LPS, however, is inconsistent with a remarkably low incidence of Gram negative infections observed in this child and other children with IRAK4-deficiency. This unpredicted clinical phenotype was validated by demonstrating that IRAK4-deficient mice had a similar resistance to infection with Gram negative S. typhimurium as wildtype mice. A number of immunity genes, such as chemokines, were expressed at normal levels in human IRAK4-deficient monocytes, indicating that particular IRAK4-independent elements within the repertoire of TLR4-induced responses are expressed.

Conclusions

Sufficient defence to Gram negative immunity does not require IRAK4 or a robust, 'classic' inflammatory and immune response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Akira S, Uematsu S, Takeuchi O: Pathogen Recognition and Innate Immunity. Cell. 2005, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRef Akira S, Uematsu S, Takeuchi O: Pathogen Recognition and Innate Immunity. Cell. 2005, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRef
2.
go back to reference Martino F, Tschoop J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 2005, 26: 449-454. Martino F, Tschoop J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 2005, 26: 449-454.
3.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.PubMedCrossRef Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.PubMedCrossRef
4.
go back to reference Dunne A, O'Neill LA: Adaptor usage and Toll-like receptor signalling specificity. FEBS Lett. 2005, 579: 3330-3335. 10.1016/j.febslet.2005.04.024.PubMedCrossRef Dunne A, O'Neill LA: Adaptor usage and Toll-like receptor signalling specificity. FEBS Lett. 2005, 579: 3330-3335. 10.1016/j.febslet.2005.04.024.PubMedCrossRef
5.
6.
7.
go back to reference Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000, 165: 5392-5396.PubMedCrossRef Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000, 165: 5392-5396.PubMedCrossRef
8.
go back to reference Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB: Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defence against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol. 2004, 172: 3377-3381.PubMedCrossRef Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB: Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defence against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol. 2004, 172: 3377-3381.PubMedCrossRef
9.
go back to reference Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B: Fatal Mycobacterium tuberculosi s infection despite adaptive immune response in the absence of MyD88. J Clin Invest. 2004, 114: 1790-1799.PubMedPubMedCentralCrossRef Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B: Fatal Mycobacterium tuberculosi s infection despite adaptive immune response in the absence of MyD88. J Clin Invest. 2004, 114: 1790-1799.PubMedPubMedCentralCrossRef
10.
go back to reference Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, Sher A: Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol. 2003, 171: 4758-4764.PubMedCrossRef Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, Sher A: Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol. 2003, 171: 4758-4764.PubMedCrossRef
11.
go back to reference Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, Futatsugi-Yumikura S, Takeuchi O, Hoshino K, Akira S, Fujimoto J, Nakanishi K: Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol. 2002, 169: 3863-3868.PubMedCrossRef Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, Futatsugi-Yumikura S, Takeuchi O, Hoshino K, Akira S, Fujimoto J, Nakanishi K: Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol. 2002, 169: 3863-3868.PubMedCrossRef
12.
go back to reference Ku CL, Yang K, Bustamante Puel A, von Bernuth A, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C: Inherited disorders of human Toll-like receptor signalling: immunological implications. Immunol Rev. 2005, 203: 10-20. 10.1111/j.0105-2896.2005.00235.x.PubMedCrossRef Ku CL, Yang K, Bustamante Puel A, von Bernuth A, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C: Inherited disorders of human Toll-like receptor signalling: immunological implications. Immunol Rev. 2005, 203: 10-20. 10.1111/j.0105-2896.2005.00235.x.PubMedCrossRef
13.
go back to reference Currie AJ, Davidson DJ, Reid GS, Bharya S, MacDonald KL, Devon RS, Speert DP: Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signalling. J Pediatr. 2004, 144: 512-518. 10.1016/j.jpeds.2003.10.034.PubMedCrossRef Currie AJ, Davidson DJ, Reid GS, Bharya S, MacDonald KL, Devon RS, Speert DP: Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signalling. J Pediatr. 2004, 144: 512-518. 10.1016/j.jpeds.2003.10.034.PubMedCrossRef
14.
go back to reference Davidson DJ, Currie AJ, Bowdish DME, Brown KL, Rosenberger CM, Ma RC, Bylund J, Campsall PA, Puel A, Picard C, Casanova JL, Turvey SE, Devon RE, Hancock REW, Speert DP: IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL1R responses in human myeloid and non-myeloid cells. J Immunol. 2006, 177: 8202-8211.PubMedPubMedCentralCrossRef Davidson DJ, Currie AJ, Bowdish DME, Brown KL, Rosenberger CM, Ma RC, Bylund J, Campsall PA, Puel A, Picard C, Casanova JL, Turvey SE, Devon RE, Hancock REW, Speert DP: IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL1R responses in human myeloid and non-myeloid cells. J Immunol. 2006, 177: 8202-8211.PubMedPubMedCentralCrossRef
15.
go back to reference Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah A, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003, 299: 2076-2079. 10.1126/science.1081902.PubMedCrossRef Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah A, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003, 299: 2076-2079. 10.1126/science.1081902.PubMedCrossRef
16.
go back to reference Medvedev AE, Lentschat A, Kuhns DB, Blanco JC, Salkowski C, Zhang S, Arditi M, Gallin JI, Vogel SN: Distinct mutations in IRAK-4 Confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med. 2003, 198: 521-531. 10.1084/jem.20030701.PubMedPubMedCentralCrossRef Medvedev AE, Lentschat A, Kuhns DB, Blanco JC, Salkowski C, Zhang S, Arditi M, Gallin JI, Vogel SN: Distinct mutations in IRAK-4 Confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med. 2003, 198: 521-531. 10.1084/jem.20030701.PubMedPubMedCentralCrossRef
17.
go back to reference Chapel H, Puel A, von Bernuth H, Picard C, Casanova JL: Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency. Clin Infect Dis. 2005, 40: 1227-1231. 10.1086/428733.PubMedCrossRef Chapel H, Puel A, von Bernuth H, Picard C, Casanova JL: Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency. Clin Infect Dis. 2005, 40: 1227-1231. 10.1086/428733.PubMedCrossRef
18.
go back to reference Enders A, Pannicke U, Berner R, Henneke P, Radlinger K, Schwarz K, Ehl S: Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4. J Pediatr. 2004, 145: 698-700. 10.1016/j.jpeds.2004.06.065.PubMedCrossRef Enders A, Pannicke U, Berner R, Henneke P, Radlinger K, Schwarz K, Ehl S: Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4. J Pediatr. 2004, 145: 698-700. 10.1016/j.jpeds.2004.06.065.PubMedCrossRef
19.
go back to reference Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 2002, 416: 750-756. 10.1038/nature736.PubMedCrossRef Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 2002, 416: 750-756. 10.1038/nature736.PubMedCrossRef
20.
go back to reference Vosse van de E, van Dissel JT, Ottenhoff TH: Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis. 2009, 9: 688-698. 10.1016/S1473-3099(09)70255-5.PubMedCrossRef Vosse van de E, van Dissel JT, Ottenhoff TH: Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis. 2009, 9: 688-698. 10.1016/S1473-3099(09)70255-5.PubMedCrossRef
21.
go back to reference Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Maródi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL: Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007, 204: 2407-2422. 10.1084/jem.20070628.PubMedPubMedCentralCrossRef Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Maródi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL: Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007, 204: 2407-2422. 10.1084/jem.20070628.PubMedPubMedCentralCrossRef
22.
go back to reference Suzuki N, Suzuki S, Eriksson U, Hara H, Mirtosis C, Chen NJ, Wada T, Bouchard D, Hwang I, Takeda K, Fujita T, Der S, Penninger JM, Akira S, Saito T, Yeh WC: IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J Immunol. 2003, 171: 6065-6071.PubMedCrossRef Suzuki N, Suzuki S, Eriksson U, Hara H, Mirtosis C, Chen NJ, Wada T, Bouchard D, Hwang I, Takeda K, Fujita T, Der S, Penninger JM, Akira S, Saito T, Yeh WC: IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J Immunol. 2003, 171: 6065-6071.PubMedCrossRef
23.
go back to reference Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H, Uematsu S, Takeuchi O, Akira S: Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signalling. J Exp Med. 2007, 204: 1013-1024. 10.1084/jem.20061523.PubMedPubMedCentralCrossRef Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H, Uematsu S, Takeuchi O, Akira S: Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signalling. J Exp Med. 2007, 204: 1013-1024. 10.1084/jem.20061523.PubMedPubMedCentralCrossRef
24.
go back to reference Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y, Xiao H, Qian W, Hamilton T, Min B, Sen G, Gilmour R, Li X: A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med. 2007, 204: 1025-1036. 10.1084/jem.20061825.PubMedPubMedCentralCrossRef Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y, Xiao H, Qian W, Hamilton T, Min B, Sen G, Gilmour R, Li X: A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med. 2007, 204: 1025-1036. 10.1084/jem.20061825.PubMedPubMedCentralCrossRef
25.
go back to reference Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, Roche RM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE: Modulation of the Toll-like receptor-mediated inflammatory response by the endogenous human host defence peptide LL-37. J Immunol. 2006, 176: 2455-2464.PubMedCrossRef Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, Roche RM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE: Modulation of the Toll-like receptor-mediated inflammatory response by the endogenous human host defence peptide LL-37. J Immunol. 2006, 176: 2455-2464.PubMedCrossRef
26.
go back to reference Hirschfeld AF, Bettinger JA, Victor RE, Davidson DJ, Currie AJ, Ansermino JM, Scheifele DW, Orange JS, Turvey SE: Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol. 2007, 122: 271-8. 10.1016/j.clim.2006.10.012.PubMedCrossRef Hirschfeld AF, Bettinger JA, Victor RE, Davidson DJ, Currie AJ, Ansermino JM, Scheifele DW, Orange JS, Turvey SE: Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol. 2007, 122: 271-8. 10.1016/j.clim.2006.10.012.PubMedCrossRef
27.
go back to reference Brown KL, Maiti A, Johnson P: Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14+ peripheral blood monocytes. J Immunol. 2001, 167: 5367-5374.PubMedCrossRef Brown KL, Maiti A, Johnson P: Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14+ peripheral blood monocytes. J Immunol. 2001, 167: 5367-5374.PubMedCrossRef
28.
go back to reference Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott M, Falsafi R, Hancock R, Speert DP: ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol. 2008, 129: 90-102. 10.1016/j.clim.2008.06.005.PubMedCrossRef Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott M, Falsafi R, Hancock R, Speert DP: ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol. 2008, 129: 90-102. 10.1016/j.clim.2008.06.005.PubMedCrossRef
29.
go back to reference Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW: An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol. 2007, 25: 465-472. 10.1038/nbt1288.PubMedCrossRef Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW: An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol. 2007, 25: 465-472. 10.1038/nbt1288.PubMedCrossRef
30.
go back to reference Hokamp K, Roche FM, Acab M, Rousseau ME, Kuo B, Goode D, Aeschliman D, Bryan J, Babiuk LA, Hancock REW, Brinkman FS: ArrayPipe: a flexible processing pipeline for microarray data. Nucl Acids Res. 2004, 32: W457-459. 10.1093/nar/gkh446.PubMedPubMedCentralCrossRef Hokamp K, Roche FM, Acab M, Rousseau ME, Kuo B, Goode D, Aeschliman D, Bryan J, Babiuk LA, Hancock REW, Brinkman FS: ArrayPipe: a flexible processing pipeline for microarray data. Nucl Acids Res. 2004, 32: W457-459. 10.1093/nar/gkh446.PubMedPubMedCentralCrossRef
31.
go back to reference Shannon P, Markiel A, Ozier Q, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303.PubMedPubMedCentralCrossRef Shannon P, Markiel A, Ozier Q, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303.PubMedPubMedCentralCrossRef
32.
go back to reference Zhang B, Schmoyer D, Kirov K, Snoddy J: GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics. 2004, 5: 16-23. 10.1186/1471-2105-5-16.PubMedPubMedCentralCrossRef Zhang B, Schmoyer D, Kirov K, Snoddy J: GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics. 2004, 5: 16-23. 10.1186/1471-2105-5-16.PubMedPubMedCentralCrossRef
33.
go back to reference Hoiseth SK, Stocker BA: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981, 291: 238-239. 10.1038/291238a0.PubMedCrossRef Hoiseth SK, Stocker BA: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981, 291: 238-239. 10.1038/291238a0.PubMedCrossRef
34.
go back to reference Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP: TLR signalling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir Res. 2004, 5: 1-10. 10.1186/1465-9921-5-1.PubMedPubMedCentralCrossRef Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP: TLR signalling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir Res. 2004, 5: 1-10. 10.1186/1465-9921-5-1.PubMedPubMedCentralCrossRef
35.
go back to reference Mahieu T, Park JM, Revets H, Paschel B, Lengeling A, Staelens J, Wullaert A, Vanlaere I, Hochepied T, van Roy F, Karin M, Libert C: The wild-derived inbred mouse strain SPRET_Ei is resistant to LPS and defective in IFN-β production. PNAS. 2006, 103: 2292-2297. 10.1073/pnas.0510874103.PubMedPubMedCentralCrossRef Mahieu T, Park JM, Revets H, Paschel B, Lengeling A, Staelens J, Wullaert A, Vanlaere I, Hochepied T, van Roy F, Karin M, Libert C: The wild-derived inbred mouse strain SPRET_Ei is resistant to LPS and defective in IFN-β production. PNAS. 2006, 103: 2292-2297. 10.1073/pnas.0510874103.PubMedPubMedCentralCrossRef
36.
go back to reference Modlin RL, Brightbill HD, Godowski PJ: The Toll of Innate Immunity on Microbial Pathogens. NEJM. 1999, 340: 1834-1835. 10.1056/NEJM199906103402312.PubMedCrossRef Modlin RL, Brightbill HD, Godowski PJ: The Toll of Innate Immunity on Microbial Pathogens. NEJM. 1999, 340: 1834-1835. 10.1056/NEJM199906103402312.PubMedCrossRef
37.
go back to reference Koziczak-Holbro M, Glück A, Tschopp C, Mathison JC, Gram H: IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur J Immunol. 2008, 38: 788-96. 10.1002/eji.200737886.PubMedCrossRef Koziczak-Holbro M, Glück A, Tschopp C, Mathison JC, Gram H: IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur J Immunol. 2008, 38: 788-96. 10.1002/eji.200737886.PubMedCrossRef
38.
go back to reference Covert MW, Leung TH, Gaston JE, Baltimore D: Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science. 2005, 309: 1854-1857. 10.1126/science.1112304.PubMedCrossRef Covert MW, Leung TH, Gaston JE, Baltimore D: Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science. 2005, 309: 1854-1857. 10.1126/science.1112304.PubMedCrossRef
39.
go back to reference Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999, 11: 115-122. 10.1016/S1074-7613(00)80086-2.PubMedCrossRef Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999, 11: 115-122. 10.1016/S1074-7613(00)80086-2.PubMedCrossRef
40.
go back to reference Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, Saitoh T, Yamaoka S, Yamamoto N, Yamamoto S, Muta Tm, Takeda K, Akira S: Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature. 2004, 430: 218-222. 10.1038/nature02738.PubMedCrossRef Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, Saitoh T, Yamaoka S, Yamamoto N, Yamamoto S, Muta Tm, Takeda K, Akira S: Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature. 2004, 430: 218-222. 10.1038/nature02738.PubMedCrossRef
41.
go back to reference Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998, 281: 1001-1005. 10.1126/science.281.5379.1001.PubMedCrossRef Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998, 281: 1001-1005. 10.1126/science.281.5379.1001.PubMedCrossRef
42.
go back to reference Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol. 1997, 158: 2898-2903.PubMed Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol. 1997, 158: 2898-2903.PubMed
43.
go back to reference Pasare C, Medzhitov R: Control of B-cell responses by Toll-like receptors. Nature. 2005, 438: 364-368. 10.1038/nature04267.PubMedCrossRef Pasare C, Medzhitov R: Control of B-cell responses by Toll-like receptors. Nature. 2005, 438: 364-368. 10.1038/nature04267.PubMedCrossRef
44.
go back to reference Denny P, Hopes E, Gingles N, Broman KW, McPheat W, Morten J, Alexander J, Andrew PW, Brown SD: A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice. Mamm Genome. 2003, 14: 448-453. 10.1007/s00335-002-2261-9.PubMedCrossRef Denny P, Hopes E, Gingles N, Broman KW, McPheat W, Morten J, Alexander J, Andrew PW, Brown SD: A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice. Mamm Genome. 2003, 14: 448-453. 10.1007/s00335-002-2261-9.PubMedCrossRef
45.
go back to reference Esche C, Stellato C, Beck LA: Chemokines: key players in innate and adaptive immunity. J Invest Dermatol. 2005, 125: 615-628. 10.1111/j.0022-202X.2005.23841.x.PubMedCrossRef Esche C, Stellato C, Beck LA: Chemokines: key players in innate and adaptive immunity. J Invest Dermatol. 2005, 125: 615-628. 10.1111/j.0022-202X.2005.23841.x.PubMedCrossRef
46.
go back to reference Björkbacka H, Fitzgerald KA, Huet F, LI X, Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT, Freeman MW: The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiological Genomics. 2004, 19: 319-330. 10.1152/physiolgenomics.00128.2004.PubMedCrossRef Björkbacka H, Fitzgerald KA, Huet F, LI X, Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT, Freeman MW: The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiological Genomics. 2004, 19: 319-330. 10.1152/physiolgenomics.00128.2004.PubMedCrossRef
47.
go back to reference Brown KL, Cosseau C, Gardy JL, Hancock REW: Complexities of targeting innate immunity to treat infection. Trends Immunol. 2007, 28: 260-66. 10.1016/j.it.2007.04.005.PubMedCrossRef Brown KL, Cosseau C, Gardy JL, Hancock REW: Complexities of targeting innate immunity to treat infection. Trends Immunol. 2007, 28: 260-66. 10.1016/j.it.2007.04.005.PubMedCrossRef
48.
go back to reference Li X: IRAK4 in TLR/IL-1R signalling: possible clinical applications. Eur J Immunol. 2008, 38: 614-618. 10.1002/eji.200838161.PubMedCrossRef Li X: IRAK4 in TLR/IL-1R signalling: possible clinical applications. Eur J Immunol. 2008, 38: 614-618. 10.1002/eji.200838161.PubMedCrossRef
Metadata
Title
Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity
Authors
Kelly L Brown
Reza Falsafi
Winnie Kum
Pamela Hamill
Jennifer L Gardy
Donald J Davidson
Stuart Turvey
Brett B Finlay
David P Speert
Robert EW Hancock
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2010
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-6

Other articles of this Issue 1/2010

Journal of Translational Medicine 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.